Cargando…
Induction of NKG2D ligand expression on tumor cells by CD8(+) T cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor
The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack. However, cancer cells escape from immune surveillance by downregulating NKG2D ligands. We previously discovered that engagement of activated CD8(+) T cells and tumor cells...
Autores principales: | Hu, Jiemiao, Xia, Xueqing, Gorlick, Richard, Li, Shulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895417/ https://www.ncbi.nlm.nih.gov/pubmed/31427736 http://dx.doi.org/10.1038/s41388-019-0960-x |
Ejemplares similares
-
CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells
por: Sauer, M, et al.
Publicado: (2017) -
CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors
por: Hu, Jiemiao, et al.
Publicado: (2014) -
Dimeric structure of p300/CBP associated factor
por: Shi, Shasha, et al.
Publicado: (2014) -
Discovery
and Optimization of Small-Molecule
Ligands for the CBP/p300
Bromodomains
por: Hay, Duncan A., et al.
Publicado: (2014) -
Nuclear Factor of Activated T Cells (NFAT)-dependent Transactivation Regulated by the Coactivators p300/CREB-binding Protein (CBP)
por: García-Rodríguez, Carmen, et al.
Publicado: (1998)